Moffatt this Seeking Alpha article supports your interpretation.
Apr. 15, 2019 8:31 AM ET|About: Bio-Path Holdings, Inc. (BPTH)|By: Douglas W. House, SA News Editor
•Nano cap Bio-Path Holdings (NASDAQ:BPTH) is up 37% premarket on increased volume in reaction to its withdrawal of an S-1 filed in late December 2018 for an offering of stock and warrants.
•Shares rocketed in early March after it announced positive data on prexigebersen, almost always an equity raise-provoking event. The stock peaked at $73.52 on March 7 before retracing. Shares closed at $15.65 on Friday, April 12.
•On March 12, it announced the direct sale of ~713K common shares at $25.95 to institutional investors so its withdrawal of the registration statement may be a tactic to get them above water.
Thanks to my buddy who sent this to me.